Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Inspire Medical Systems, Inc.INSP · Entity 1186 | See Remarks | February 20, 2026 | February 24, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Inspire Medical Systems, Inc.
Report date February 20, 2026 · Filed February 24, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 41,679 |
Ending reported balance
After 2026-02-20 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-02-20 · Grant · Acquired 2,196 · Balance 8,756 F1: Reflects an award of shares of common stock following the satisfaction of performance conditions associated with previously granted performance stock units. Row 2 · 2026-02-20 · Tax withholding · Disposed 672 · Balance 8,084 F2: Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a performance stock unit award. Row 3 · 2026-02-20 · Grant · Acquired 20,997 · Balance 29,081 F3: Represents an award of restricted stock units ("RSUs"), which vests in three equal annual installments commencing on February 20, 2027. Each RSU represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant dates. Row 4 · 2026-02-20 · Grant · Acquired 12,598 · Balance 41,679 F3: Represents an award of restricted stock units ("RSUs"), which vests in three equal annual installments commencing on February 20, 2027. Each RSU represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant dates. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects an award of shares of common stock following the satisfaction of performance conditions associated with previously granted performance stock units.
F2: Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a performance stock unit award.
F3: Represents an award of restricted stock units ("RSUs"), which vests in three equal annual installments commencing on February 20, 2027. Each RSU represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant dates.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 20, 2026 Filed Feb 24, 2026 23:58 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 12,598 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-019275 · tm267181-3_4seq1.xml · nonDerivative · entry 4 Weatherby Carlton · CIK 0001986335 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,679 F3 · shares: Represents an award of restricted stock units ("RSUs"), which vests in three equal annual installments commencing on February 20, 2027. Each RSU represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant dates. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 23:58 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 20,997 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-019275 · tm267181-3_4seq1.xml · nonDerivative · entry 3 Weatherby Carlton · CIK 0001986335 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,081 F3 · shares: Represents an award of restricted stock units ("RSUs"), which vests in three equal annual installments commencing on February 20, 2027. Each RSU represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant dates. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 23:58 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Tax withholdingCommon Stock | 672 | $59.53 | $40,004.16 |
DisclosureSEC source: 0001104659-26-019275 · tm267181-3_4seq1.xml · nonDerivative · entry 2 Weatherby Carlton · CIK 0001986335 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,084 F2 · shares: Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a performance stock unit award. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 23:58 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 2,196 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-019275 · tm267181-3_4seq1.xml · nonDerivative · entry 1 Weatherby Carlton · CIK 0001986335 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,756 F1 · shares: Reflects an award of shares of common stock following the satisfaction of performance conditions associated with previously granted performance stock units. Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 21:06 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Tax withholdingCommon Stock | 570 | $59.76 | $34,063.20 |
DisclosureSEC source: 0001104659-26-017044 · tm266746-2_4seq1.xml · nonDerivative · entry 1 Weatherby Carlton · CIK 0001986335 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,560 F1 · shares: Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a restricted stock unit award. Read SEC document |
| February 09, 2026 Filed Feb 11, 2026 22:23 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Tax withholdingCommon Stock | 327 | $66.33 | $21,689.91 |
DisclosureSEC source: 0001104659-26-013540 · tm266005-5_4seq1.xml · nonDerivative · entry 1 Weatherby Carlton · CIK 0001986335 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,130 F1 · shares: Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a restricted stock unit award. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 23:48 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 5,076 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-014870 · tm256927-7_4seq1.xml · nonDerivative · entry 2 Weatherby Carlton · CIK 0001986335 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,457 F1 · shares: Represents an award of restricted stock units, which vests in three equal annual installments commencing on February 13, 2026. Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| February 09, 2025 Filed Feb 18, 2025 23:48 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Tax withholdingCommon Stock | 313 | $182.15 | $57,012.95 |
DisclosureSEC source: 0001104659-25-014870 · tm256927-7_4seq1.xml · nonDerivative · entry 1 Weatherby Carlton · CIK 0001986335 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,381 Read SEC document |
| February 09, 2024 Filed Feb 14, 2024 02:33 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantEmployee Stock Option (Right to Buy) · Derivative | 4,376 | $0.00 Strike: $194.87 | $0.00 |
DisclosureSEC source: 0001104659-24-022561 · tm245999-2_4seq1.xml · derivative · entry 2 Weatherby Carlton · CIK 0001986335 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,376 Underlying: Common Stock · 4,376 shares Expires 2034-02-09 F2 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the underlying shares on February 9, 2025. The remaining 75% of the underlying shares will vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| February 09, 2024 Filed Feb 14, 2024 02:33 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 2,694 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-022561 · tm245999-2_4seq1.xml · nonDerivative · entry 1 Weatherby Carlton · CIK 0001986335 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,694 F1 · shares: Represents an award of restricted stock units, which vests in three equal annual installments commencing on February 9, 2025. Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 20:05 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantEmployee Stock Option (Right to Buy) · Derivative | 4,452 | $0.00 Strike: $287.81 | $0.00 |
DisclosureSEC source: 0001104659-23-086791 · tm2322533-2_4seq1.xml · derivative · entry 1 Weatherby Carlton · CIK 0001986335 · Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,452 Underlying: Common Stock · 4,452 shares Expires 2033-07-31 F1 · derivative.exercise_date: The option has vested or will vest and become exercisable as to 25% of the underlying shares on the first anniversary of July 31, 2023 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.